FierceBiotech Feb 4, 2026 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
BioPharma Dive Feb 4, 2026 Lilly soars again as fast-selling weight loss drugs top Wall Street projections
PharmaVoice Jan 29, 2026 Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
FierceBiotech Jan 29, 2026 Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
BioPharma Dive Jan 28, 2026 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
FierceBiotech Jan 28, 2026 Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
Endpoints News Jan 27, 2026 CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Endpoints News Jan 23, 2026 Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO
PharmaVoice Jan 14, 2026 Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs
FierceBiotech Jan 12, 2026 JPM26, Day 1: Stock market titans Lilly, Nvidia expand team-up with AI co-innovation lab
FierceBiotech Jan 12, 2026 Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment